Seer Stock Quote SEER - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.62

Bid

1.62

Ask

1.69

Volume

339,627

1.60 Day's Range 1.64

1.455 52 Week Range 5.65

Market Cap

106.496M

Previous Close

1.64

Open

1.63

Last Trade

1.62

Last Trade Time

Financial Volume

$ 550,305

VWAP

1.6203

Average Volume (3m)

654,341

Shares Outstanding

64,936,680

Dividend Yield

PE Ratio

-1.21

Earnings Per Share (EPS)

-1.33

Revenue

16.66M

Net Profit

-86.28M

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased... Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Show more

Sector

Lab Analytical Instruments

Industry

Lab Analytical Instruments

Website

www.seer.bio

Headquarters

Wilmington, Delaware, USA

Founded

1970

Seer Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker SEER. The last closing price for Seer was $1.64. Over the last year, Seer shares have traded in a share price range of $ 1.455 to $ 5.65.

Seer currently has 64,936,680 shares outstanding. The market capitalization of Seer is $106.50 million. Seer has a price to earnings ratio (PE ratio) of -1.21.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery

Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Creation of first-of-its-kind comprehensive atlas of molecular and...

Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study

REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.16	-8.98876404494	1.78	1.81	1.6	2423932	1.67691442	CS
4	-0.13	-7.42857142857	1.75	1.91	1.6	935616	1.70371151	CS
12	-0.12	-6.89655172414	1.74	2.3	1.6	654341	1.81649285	CS
26	-0.22	-11.9565217391	1.84	2.3	1.51	530916	1.81508124	CS
52	-2.42	-59.900990099	4.04	5.65	1.455	439303	1.98987505	CS
156	-29.38	-94.7741935484	31	45.85	1.455	416804	10.86863426	CS
260	-46.38	-96.625	48	86.55	1.455	427924	17.97617513	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BENFBeneficient	$ 4.785 (122.56%)	46.48M
SHOTWSafety Shot Inc	$ 0.33 (83.33%)	1.6k
QLGNQualigen Therapeutics Inc	$ 0.28 (59.64%)	244.69M
INVZWInnoviz Technologies Ltd	$ 0.2499 (51.91%)	17.79k
ZAPPZapp Electric Vehicles Group Ltd	$ 4.06 (49.26%)	50.34M
VEVVicinity Motor Corporation	$ 0.391 (-30.67%)	409.44k
SKYESkye Bioscience Inc	$ 5.495 (-26.34%)	354.28k
CLEUChina Liberal Education Holdings Ltd	$ 2.16 (-24.74%)	13.42M
JZXNJiuzi Holdings Inc	$ 2.60 (-23.53%)	57.7k
WHLRWheeler Real Estate Investment Trust Inc	$ 15.02 (-23.01%)	30.36k
MAXNMaxeon Solar Technologies Ltd	$ 0.2378 (36.98%)	520.76M
QLGNQualigen Therapeutics Inc	$ 0.28 (59.64%)	244.69M
NVDANVIDIA Corporation	$ 125.83 (-1.91%)	214.21M
TSLATesla Inc	$ 251.52 (2.08%)	154.53M
SIRISirius XM Holdings Inc	$ 3.715 (5.24%)	121.14M